Brian Albarran, Ph.D. - Publications
Affiliations: | 2005 | University of Washington, Seattle, Seattle, WA |
Area:
Biomedical Engineering, Cell Biology, PharmacyYear | Citation | Score | |||
---|---|---|---|---|---|
2011 | Albarran B, Hoffman AS, Stayton PS. Efficient Intracellular Delivery of a Pro-Apoptotic Peptide With A pH-Responsive Carrier. Reactive & Functional Polymers. 71: 261-265. PMID 21499545 DOI: 10.1016/J.Reactfunctpolym.2010.09.008 | 0.553 | |||
2007 | Rinne J, Albarran B, Jylhävä J, Ihalainen TO, Kankaanpää P, Hytönen VP, Stayton PS, Kulomaa MS, Vihinen-Ranta M. Internalization of novel non-viral vector TAT-streptavidin into human cells. Bmc Biotechnology. 7: 1. PMID 17199888 DOI: 10.1186/1472-6750-7-1 | 0.639 | |||
2006 | Rinne J, Albarran B, Jylhävä J, Ihalainen TO, Kankaanpää P, Hytönen VP, Stayton PS, Kulomaa MS, Vihinen-Ranta M. 188. Internalization of Novel Delivery Vector TAT-Streptavidin into Human Cells Molecular Therapy. 13: S73. DOI: 10.1016/J.Ymthe.2006.08.212 | 0.649 | |||
2005 | Albarran B, To R, Stayton PS. A TAT-streptavidin fusion protein directs uptake of biotinylated cargo into mammalian cells. Protein Engineering, Design & Selection : Peds. 18: 147-52. PMID 15820981 DOI: 10.1093/Protein/Gzi014 | 0.613 | |||
2005 | Albarran B, To R, Stayton P. 1111. TAT-Streptavidin: A Novel Drug Delivery Vector for the Intracellular Uptake of Macromolecular Cargo Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.659 | 0.602 | |||
Show low-probability matches. |